Epic Research is a leading financial services provider with presence in Indian and other global capital markets. Provides Stock Tips, Forex Tips, Commodity Tips, MCX Tips, Equity Tips, Tips, Intraday Tips, NSE Tips, BSE Tips, COMEX Tips, PCG Pack and NCDEX Tips. We provide services in equity, commodity and Forex market.

1. Weekly Equity Report (26 Mar 2012)
Weekly News Hitting Indian Market
 India's CAG report on coal mining scam rattles Parliament.
 Rupee hits two-month low...Slips below 51 per $.
 Tech Mahindra-Satyam merger ratio fixed at 2:17.
 RBI tightens norms for gold loan companies.
 China’s flash manufacturing PMI slips in March.

 Dinesh Trivedi stays Railway Minister till Mar 30.
Weekly trend of the Market
 RBI leaves repo rate, CRR unchanged.
 India's industrial output accelerates in January.
 Inflation concerned the two big worries are
As far as India isclimbs due to costlier food prices. sticky crude oil and persistent policy inertia at
the Centre. Even the RBI waiting for these two variables to sort of ease a wee bit before it starts

slashing rates. Estimates of potential quantum of rate cuts by the RBI have been scaled back after the
Budget. All eyes are on the Government’s economic managers to see whether they are able to
 India's industrial output growth slumps again.
take the requisite decisions to pump- prime the domestic economy. On the global front, market
participants seeks 15% quota worried about the in buybacks.China even as concerns prevail over the sorry
 SEBI are increasingly for small investors situation in
state of the euro zone.
 Sensex slips on IIP data...Nifty holds 5350.
The win-loss score line for the Indian market now stands at 7 to 5. The strong momentum that one saw

early inIndia's trade with Europe touches US$107bn. big events of March. It looks like market players are
the year has clearly subsided now post the
resigned to another grinding year ahead with no clear bias. At the same time, there is no dearth of
headwinds at the moment. It will take a while for these uncertainties to abate.

2. www.epicresearch.co+919993959693
Weekly Nifty Gainers
COMPANY CURR.RATE VOL PREV.CL CHANGE NET CHG
Sun Pharma 580.40 3984.49 545.75 34.65 6.35
HUL 403.10 2672.92 390.20 12.90 3.31
Hero Moto 2017.45 358.53 1957.00 60.45 3.09
ITC 222.45 43904.78 216.15 6.30 2.91
Ambuja 173.10 1985.09 168.60 4.50 2.67
Weekly Nifty Losers
COMPANY CURR.RATE VOL PREV.CL CHANGE NET CHG
JSPL 535.90 1999.08 575.15 -39.25 -6.82
Hindalco 131.40 7907.17 140.85 -9.45 -6.71
R Power 121.85 13741.06 130.60 -8.75 -6.70
IDFC 135.15 10471.58 144.85 -9.70 -6.70
R Infra 594.95 3137.84 632.95 -38.00 -6.00
Weekly Nifty pivots
Pivot R4 R3 R2 R1 PP S1 S2 S3 S4
Nifty 5829 5649 5469 5374 5289 5194 5109 4929 4749
www.epicresearch.co +919993959693

3. www.epicresearch.co+919993959693
Weekly Nifty chart
Weekly BANK Nifty chart
www.epicresearch.co +919993959693

4. www.epicresearch.co+919993959693
Disclaimer
The information and views in this report, our website & all the service we provide are believed to be reliable, but we do not
accept any responsibility (or liability) for errors of fact or opinion. Users have the right to choose the product/s that suits
them the most.
Sincere efforts have been made to present the right investment perspective. The information contained herein is based on
analysis and up on sources that we consider reliable.
This material is for personal information and based upon it & takes no responsibility
The information given herein should be treated as only factor, while making investment decision. The report does not
provide individually tailor-made investment advice. Epic research recommends that investors independently evaluate
particular investments and strategies, and encourages investors to seek the advice of a financial adviser. Epic research shall
not be responsible for any transaction conducted based on the information given in this report, which is in violation of rules
and regulations of NSE and BSE.
The share price projections shown are not necessarily indicative of future price performance. The information herein,
together with all estimates and forecasts, can change without notice. Analyst or any person related to epic research might be
holding positions in the stocks recommended. It is understood that anyone who is browsing through the site has done so at
his free will and does not read any views expressed as a recommendation for which either the site or its owners or
anyone can be held responsible for . Any surfing and reading of the information is the acceptance of this disclaimer.
All Rights Reserved.
Investment in equity & bullion market has its own risks.
We, however, do not vouch for the accuracy or the completeness thereof. we are not responsible for any loss incurred
whatsoever for any financial profits or loss which may arise from the recommendations above epic research does not
purport to be an invitation or an offer to buy or sell any financial instrument. Our Clients (Paid Or Unpaid), Any third party or
anyone else have no rights to forward or share our calls or SMS or Report or Any Information Provided by us to/with anyone
which is received directly or indirectly by them. If found so then Serious Legal Actions can be taken.
www.epicresearch.co +919993959693